继发性硬化性胆管炎研究进展  

Research progress in secondary sclerosing cholangitis

作　　者：杨栋良 李晶晶[1] 贾波 季静[2] 袁雪丽[1] 杨昌振 单思乔 张韬 林铭宇 王思远 姜楠[1] 金烁 曾建平[1] Yang Dongliang;Li Jingjing;Jia Bo;Ji Jing;Yuan Xueli;Yang Changzhen;Shan Siqiao;Zhang Tao;Lin Mingyu;Wang Siyuan;Jiang Nan;Jin Shuo;Zeng Jianping;无(Hepatopancreatobiliary Center,Beijing Tsinghua Changgung Hospital,School of Clinical Medicine,Tsinghua University,Beijing 102218,China;Department of Anesthesiology,Beijing Tsinghua Changgung Hospital,School of Clinical Medicine,Tsinghua University,Beijing 102218,China;Department of Hepatobiliary and Pancreatic Surgery,General Surgery Center,First Hospital of Jilin University,Changchun 130021,China)

机构地区：[1]清华大学附属北京清华长庚医院肝胆胰中心,清华大学临床医学院,北京102218 [2]清华大学附属北京清华长庚医院麻醉科,清华大学临床医学院,北京102218 [3]吉林大学第一医院普通外科中心肝胆胰外科,长春130021

出　　处：《中华实验外科杂志》2025年第1期178-180,共3页Chinese Journal of Experimental Surgery

基　　金：国家自然科学基金重大项目(82090054);清华大学精准医学科研计划(10001020123、2022TS014);北京市医院管理中心临床医学发展专项经费资助(YGLX202329);北京清华长庚医院研究基金(12023C01004)。

摘　　要：继发性硬化性胆管炎(SSC)是一种少见胆道疾病,可继发于多种疾病,临床医生对其认识较少。本文拟综合SSC最新研究进展,将其病因、临床特征、诊断及治疗现状进行综述,以提高临床医生对其了解。Secondary sclerosing cholangitis(SSC)is a rare biliary tract disorder that can occur secondary to various diseases,and it is poorly recognized by clinicians.This article aims to comprehensively review the latest research advancements in SSC,summarizing its etiology,clinical characteristics,diagnosis,and current treatment status,in order to enhance clinicians’understanding of the disease.

关 键 词：继发性硬化性胆管炎 研究 

分 类 号：R575.7[医药卫生—消化系统]